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The fissure: interlobar collateral ventilation and 
implications for endoscopic therapy in emphysema
Theodoor David Koster
Dirk-Jan Slebos
Department of Pulmonary Diseases, 
University Medical Center Groningen, 
University of Groningen, Groningen, 
the Netherlands
Abstract: In patients with severe emphysema, bronchoscopic lung volume reduction using 
one-way valves is a promising therapeutic option to improve lung function and quality of life. 
The goal of this treatment is to achieve a complete lobar atelectasis. In a significant proportion 
of patients, this atelectasis cannot be achieved due to interlobar collateral ventilation. This 
collateral ventilation is generated through incomplete lobar fissures. Therefore, only patients 
with complete fissures and no collateral ventilation can be selected for endobronchial therapy 
with one-way valves.
Incomplete fissures are very common and exhibit a great variation in anatomy. The reported 
prevalence is 17%–85% for the right major fissure, 19%–74% for the left major fissure, and 
20%–90% for the minor fissure. There are several methods of measuring or predicting the pres-
ence of collateral ventilation, with computed tomography (CT)-fissure analysis and the Chartis 
measurement being the most important. CT-fissure analysis is an indirect method to measure 
the completeness of fissures as a surrogate for collateral ventilation. The Chartis system is an 
endobronchial method to directly measure the presence of collateral ventilation. Both methods 
have unique value, and the combination of both can accurately predict the treatment response to 
the bronchoscopic placement of endobronchial valves. This review provides an in-depth view of 
lung fissure and collateral ventilation to help understand its importance in selecting the appropriate 
patients for new emphysema treatments and thus avoid useless treatment in unsuitable patients.
Keywords: BLVR, ELVR, HRCT, one-way valve, bronchoscopy, collateral respiration, 
COPD
Introduction
In patients with severe emphysema, lung volume reduction surgery (LVRS) can 
improve the quality of life, exercise capacity and lung function.1 However, LVRS 
is a highly invasive therapy and is associated with significant morbidity.1 Therefore, 
other and less invasive techniques for reduction of lung volume have been studied. An 
emerging therapy for patients with severe emphysema is bronchoscopic lung volume 
reduction (BLVR). Several BLVR techniques have been investigated, including 
one-way endobronchial valves (EBVs) and lung volume reduction coils.2 In patients 
with severe emphysema, treatment with one-way valves shows promising results.3 
The purpose of this technique is to induce atelectasis in the most diseased lobe. Like 
LVRS, this might relieve symptoms in emphysema patients through a reduction in 
hyperinflation, with an improved function of diaphragm and chest wall mechanics. 
Furthermore, increase in elastic recoil pressure leads to increased expiratory airflow 
and the inhomogeneity of ventilation and perfusion is decreased, leading to an improve-
ment in gas exchange.1,4
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However, to achieve maximal clinical improvement with 
one-way valve treatment, it is important to achieve complete 
lobar atelectasis.4–6 The most important factor that may prevent 
the development of this desired atelectasis after endobronchial 
one-way valve treatment is interlobar collateral ventilation 
(CV) through means of an incomplete interlobar fissure.4,6 
This led to the development of several methods to measure 
the CV and investigate the interlobar fissure integrity.
A combination of these measurements, together with 
endobronchial treatment using one-way valves, leads to new 
and successful treatment of chronic obstructive pulmonary 
disease (COPD).3 The use of the proper selection criteria 
enables customized care specifically applied to the individual 
patient, thereby showing real personalized medicine.
This review will focus on the prevalence, assessment, 
and important role of CV and interlobar fissures with respect 
to BLVR.
Collateral ventilation
CV is defined as “the ventilation of alveolar structures 
through passages or channels that bypass the normal 
airways”.7 Intralobar CV (CV within a lobe, segment, or 
subsegment) was originally described as collateral respira-
tion by Van Allen et al8 in 1931. They observed that after 
obstruction of the bronchus of an airway, this was not always 
followed by alveolar collapse.
There are three main candidate pathways for CV to take 
place (Figure 1). The first described pathway consists of inter-
alveolar communication of air through the pores of Kohn. 
These are situated in alveolar walls and should permit the 
passage of fluid and possibly air. However, these pores are 
small (,5 μm) and very high pressures (estimated 19.2 kPa 
or 196 cmH
2
O) would be necessary for air transport.9–13 
A second possible pathway is through accessory communica-
tion channels (30 μm in diameter) between distal bronchioles 
and alveoli, as described by Lambert.14 The third pathway 
is described by Martin13 and contains accessory respira-
tory bronchioles between the bronchioles of adjacent lung 
segments. This pathway is probably the most important 
pathway, due to the larger size (80–150 μm) of bronchioles 
and thus having a lower resistance when compared to the 
other pathways.12,13,15
In healthy persons, CV does not seem to play an impor-
tant role, as the resistance of the collateral channels is much 
higher than the regular airways and large pressure gradients 
are needed for CV.12,16 It is not exactly known why collateral 
channels exist or why they develop, but they all seem to 
originate after birth of both animals and humans.13
Despite their origin, CV may assume importance in 
several diseases. The prevention of atelectasis after obstruc-
tion is probably the most important function of CV. For 
example, obstruction of airways by mucus impaction, tumor or 
foreign bodies does not always lead to atelectasis due to CV.8 
Furthermore, in patients with emphysema, with increased airway 
resistance, collateral resistance is lower. This was demonstrated 
by Hogg et al,18 who measured the resistance of CV in excised 
normal and emphysematous lungs. In normal lungs, the resis-
tance of collateral channels was 260–330 cmH
2
O (25–324 kPa), 
whereas this was 5–20 cmH
2
O (0.5–2.0 kPa) in emphysematous 
lungs. Therefore, air flows much more easily through collateral 
channels in an emphysematous than a normal lung.17 Although 
CV was first only described as intralobar ventilation, there is 
also interlobar (ie, between the lobes) CV across the fissures. 
Probably due to the same mechanism, the flow between different 
lobes is higher in patients with emphysema.15,17,18
Obviously, interlobar CV is an important factor in BLVR 
therapy, as this therapy is based on complete atelectasis of 
a lobe (Figure 2). Most probably, incomplete fissures are 





Figure 1 Three different pathways for collateral ventilation.
Notes: Interalveolar ventilation through the pores of Kohn. Bronchiole–alveolar 








Figure 2 Collateral ventilation.
Notes: Schematic figure illustrating the role of intra- and interlobar collateral 
ventilation, and the implications for bronchoscopic lung volume reduction using one-
way endobronchial valves. The interlobar collateral ventilation from the left upper 
to the left lower lobe, impedes the desired atelectasis of the lower lobe. Because 
all segments of the left lower lobe have endobronchial valves, intralobar collateral 
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The role of the fissure in emphysema
found in every study regarding this subject.6,15 There is no 
literature regarding the mechanism of CV in incomplete fis-
sures between lobes. It can be assumed that the mechanism of 
collateral flow between lobes is the same as within a lobe.
Embryology
Incomplete fissures are present in the majority of people and 
arise during fetal development. Approximately 4 weeks after 
conception, the airways start to develop. The respiratory 
diverticulum branches into two lung buds, which divide in 
the lobar bronchi.19
During the development of the fetus, the coelomic cavity 
is divided into the pericardium, the pleural cavities, and the 
peritoneal cavity. The pleural cavity is lined by a mesothelial 
membrane, the pleura. As the lung buds grow into the left 
and right pleural cavities, they are still covered by this mem-
brane. The membrane covering the pleural cavity becomes 
the parietal pleura, whereas the mesothelial covering of the 
lung buds becomes the visceral pleura. As early as the visceral 
pleura has formed (after around 7 weeks), invaginations of the 
pleura start to separate the lobar bronchi. This gives rise to the 
lobar fissure and formation of the lung lobes. However, lobes 
can be fused if the pleura does not cover the complete lobe, 
leading to “incomplete fissures”. As the pleura invaginates 
from lateral, it can be assumed that the fissures are incomplete 
near the hilus most often, as will be described later.19,20
Anatomy and prevalence of incomplete 
fissures
The anatomy of fissures and the completeness of fissures 
have been studied postmortem and by computed tomography 
(CT). Both the orientation (eg, medially, laterally) and the 
configuration (eg, concave, convex) exhibits a large varia-
tion. A large study performed by Aziz et al,21 described the 
anatomy of the pulmonary fissures using high-resolution 
computed tomography (HRCT) in 662 patients without 
significant pulmonary disease. For the left major fissure, 
they found that, in most cases, the fissure faces medial in the 
superior zone (66%), lateral in the suprahilar zone (64%), and 
medial in the infrahilar and inferior zones (54% and 68%, 
respectively).21 For the right major fissure, the fissure faces 
medial in the superior zone (85%) and lateral in the lower 
zones (63% suprahilar, 55% infrahilar, and 62% inferior). 
Other studies partly describe the same orientations, but 
individual variation is large.22–25
There is also some variation in the reported degree of 
incompleteness of the fissures. Some studies were based 
on autopsies. For example, Raasch et al22 studied 100 lung 
specimens and found that incomplete fissures are very 
common. The incidence ranged from 70% in the right major 
fissure (mainly superior), 46% across the left major fissure 
(mainly inferior) and 94% across the minor fissure.22 Other 
cadaver studies reported incomplete horizontal fissures in 
47%–63% of cases, 36%–47% incomplete left oblique fissures, 
and 37%–39% incomplete right oblique fissures.26,27
Studies using CT also mention variable numbers, which 
are summarized in Table 1. The reported prevalence of 
incomplete fissures is 17%–85% for the right major fissure, 
19%–74% for the left major fissure, and 20%–90% for the 
minor fissure.21,23,28–35 These studies consistently find that 
compared to the other fissures, the minor fissure is incomplete 
most frequently. Furthermore fissures are incomplete near the 
hilus most frequently.21,30 The reported prevalence exhibits a 
great variation. Possible explanations are the varying patient 
groups with and without pulmonary disease, different kind 
of reviewers, various or no criteria to define an incomplete 
fissure, or used CT-scan technique (eg, slide thickness).34
Measurement of Cv
There are several methods to assess the presence of CV. 
Invasive measurement methods include nuclear techniques and 
an endobronchial pulmonary assessment system. Noninvasive 
methods for measurement of CV include imaging techniques 
such as hyperpolarized gas magnetic resonance imaging (MRI) 
or CT-fissure analysis, which is an indirect method.
Endobronchial CV assessment
Although several endobronchial methods has been described 
for endobronchial assessment of CV, the study of Aljuri and 
Freitag36 in 2009 was the first to present a method assessing col-
lateral flow to predict the clinical response to BLVR treatment. 
Based on this technique the Chartis System® (PulmonX Inc., 
Redwood City, CA, USA) was developed, and is described 
and used in several articles regarding this topic.3,37–41
The Chartis system consists of a catheter with a bal-
loon component at the distal tip (Figure 3A). After infla-
tion of the balloon, the airway is blocked and air from the 
targeted segment or lobe can flow only through the catheter 
(Figure 3B). The air is directed to the Chartis console, which 
can assess both expiratory air flow, pressure, and resistance 
(Figure 3C–E). If expiratory airflow persists after occlusion 
of a lobe, this indicates the presence of collateral airflow. In 
contrast, if there is no more flow, this indicates high collateral 
resistance and thus no collateral airflow, indicating a suitable 
candidate for BLVR therapy (Figures 2 and 3).42
Gompelmann et al43 performed the first clinical trial with 
the Chartis system in 2010 and showed that in 90% of the 
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on chest radiograph would occur. A subsequent larger study 
by Herth et al44 investigated the diagnostic value of the 
Chartis pulmonary assessment system to predict treatment 
response, defined as a target lung volume reduction (TLVR) 
of 350 mL or more. There was a total accuracy of 75%, with 
a positive predictive value of 71% and negative predictive 
value of 83%.
For optimal result and reliability of the Chartis measure-
ment, there are several technical aspects to consider. For 
example, coughing or multiple mucus plugs might impede 
the measurement. Furthermore, especially in the lower lobes, 
the balloon might occlude a segment – for example, B6 in the 
left lower lobe – so that this segment may not get included in 
the assessment of CV. Moreover, dynamic airway collapse 
can occur, which might show as an abrupt or gradual ending 
of flow, with ,100 mL of total exhaled air. To maximize the 
chance of a successful and reliable measurement, adequate 
training is required.37,43,45,46 Furthermore, the measurement 
can be performed under general anesthesia with positive pres-
sure support (Figure 3E), or high frequency jet ventilation. 
This creates optimal circumstances for a reliable and fast 
measurement, and if there is no CV, the treatment with 
EBVs can take place immediately, in the same treatment 
session (Figure 4).
Nuclear techniques
Nuclear imaging can be used to demonstrate the presence 
of CV. For example, Morrell et al47 measured CV using 
a balloon-tipped catheter, to occlude segmental bronchi. 
Subjects then breathed heliox (79% helium, 21% oxygen) and 
Table 1 Prevalence of incomplete fissures
Author
(year)
Subjects (N) Research Measurement Incomplete (%) Patient group/remarks
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exclusion: lung lesions around 
interlobar fissures





Exclusion: advanced fibrosis, 
kyphoscoliosis, chest 
deformity, massive pleural 
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Pu et al35 (2014) 573 HRCT •	 Computerized RMF: 74
LMF: 75
MF: 86
Healthy population and 
COPD-patients
Notes: *Diagnostic criteria: 1) neither a clear avascular zone nor interlobar line is observed; 2) vascular images in adjacent lobes cross over the interlobar region; 
3) pulmonary blood vessels, particularly the pulmonary vein, penetrate the interlobar region; 4) the pulmonary vein is observed in the interlobar region and is related to the 
vascular images in adjacent lobes. #Consensus: individual evaluation of fissure and classified as complete or incomplete, consensus with colleagues.
Abbreviations: HRCT, high-resolution computed tomography; MDCT, multidetector computed tomography; RMF, right major fissure/right oblique fissure; LMF, left 
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The role of the fissure in emphysema
the rise of helium concentration in the occluded segment was 
used as index for CV. Another study used 133Xenon ventila-
tion scintigraphy to prove the presence of interlobar CV, by 
selectively intubating a lobe and measuring the ventilation 
of the adjacent lobes.48
Currently, there are no studies that compared the use of 
nuclear technique with Chartis measurement or CT-fissure 
analysis, nor their predictive values for developing atelectasis 
after endobronchial lung volume reduction therapy.
Another, noninvasive, method to measure CV was 
described by Marshall et al.49 In this study, a mix of hyper-
polarized 3He and N
2
 was inhaled and 3He images were 
acquired using MRI during a single breath-hold. They found 
ventilation defects with delayed filling in a large proportion 
of patients. Although this delayed filling may be due to 
several causes (eg, CV, air trapping), the specific pattern of 
3He filling from the edges of the ventilation defect toward 
the centre was believed to be due to CV.
Figure 3 Chartis measurement.
Notes: (A) The Chartis balloon at the distal tip of the catheter. (B) Bronchoscopic view of the Chartis balloon blocking the entrance to the right lower lobe to measure 
collateral ventilation to this lobe. (C) Example of a negative Chartis measurement with absence of collateral ventilation, measured in spontaneous breathing patient. The 
orange pattern shows the expired flow (mL/min). The decrease of the flow pattern indicates there is no collateral flow. The blue pattern shows the negative intrapleural 
pressure (cmH2O) and indicates the quality of the occlusion by the balloon. (D) example of a positive Chartis measurement with collateral ventilation, as there is no decline 
in the expired flow. (E) Example of a negative Chartis measurement with absence of collateral ventilation, measured in a sedated patient with positive pressure ventilation. 
Therefore, only the decreasing flow pattern is shown, indicating there is no collateral flow.







































Figure 4 Implanted one-way endobronchial valve.
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However, although CV may be demonstrated by this 
method, it demonstrates intersegmental and not the interlobar 
CV. Therefore, this method is probably less valuable to predict 
the response to BLVR. Moreover, its availability is probably 
less than the other measurement methods in most clinics.
CT-fissure analysis
A surrogate- or indirect method for the measurement of CV 
is by using CT-fissure analysis. CT can be used to assess the 
completeness of the fissure. If a fissure is complete, there is 
most probably no CV. However, if the fissures are incomplete 
and lobes are fused, CV is very likely. Usually, the analysis is 
done by experienced radiologists or pulmonologists, but it is 
prone for interobserver variability.
Several authors described the following diagnostic criteria 
for incomplete interlobar fissures: “1) neither a clear avascu-
lar zone nor interlobar line is observed; 2) vascular images in 
adjacent lobes cross over the interlobar region; 3) pulmonary 
blood vessels, particularly the pulmonary vein, penetrate 
the interlobar region; 4) the pulmonary vein is observed in 
the interlobar region and is related to the vascular images in 
adjacent lobes.”30,32,34 Other authors did not use predefined 
diagnostic criteria, but they used consensus or experts opinion 
to describe the fissures as complete or incomplete.23,28,29,31,33
Interobserver agreement was investigated by several 
authors. Koenigkam-Santos et al29 described a high agreement 
between experienced radiologists for the major fissures, but 
rather moderate for the minor fissure (k=0.53). Cronin et al31 
described a greater than 90% agreement for all fissures, Guan 
et al34 found a fair to nearly perfect agreement between two 
radiologists (k=0.593–0.652) and Koenigkam-Santos et al28 
described a reported interobserver agreement of 0.70–0.76. 
This is the case with experienced radiologists or pneumologists; 
inexperienced readers most probably have lower agreement.
Several studies compared the results of CT to intraop-
erative assessment of the fissures. For example, Diso et al38 
evaluated a group of 21 patients undergoing surgery for lung 
cancer and then compared the intraoperative assessment of 
fissures to both the Chartis and HRCT measurement of fis-
sures. Compared to inspection at surgery, Chartis measure-
ment had an accuracy of 71% and HRCT of 76%; there was 
no significant difference between them. Kent et al50 compared 
CT to intraoperative assessment and also found high predic-
tive values for both major fissures but a positive predictive 
value of only 33% for the minor fissure.
More recently, automatic methods have been developed 
to quantify the completeness of the fissures. Several of 
these methods have been described and used in literature, 
and the results are comparable to the interpretation of 
radiologists.35,37,51
Studies comparing CT-fissure analysis and Chartis
The response of valve-based lung volume reduction can be 
predicted by both the Chartis measurement and the CT-fissure 
analysis. An interesting question is which of these methods 
is better to predict this response, or if a combination of both 
is better.
Currently, there are few studies that compare these 
methods. Schuhmann et al37 retrospectively compared CT to 
the Chartis measurement in a testing dataset of 33 patients. 
A positive response to treatment was defined as a target lung 
volume reduction of 350 mL or more. The authors concluded 
that CT-fissure was comparable with Chartis (P=0.55) with 
an accuracy of 75.8% for Chartis and 78.8% for CT. In this 
study, both methods disagreed in eleven of 33 subjects, and 
the proportion of misclassifications was equal between both 
methods. However, in 22 of 33 subjects, the methods agreed 
and the classification into responders and nonresponders was 
90.9% correct. There were no false negatives in subjects clas-
sified as nonresponders by both Chartis and CT. Two patients 
were misclassified as responders, but that was due to valve 
procedural errors in these patients. These results suggest that 
an agreement of both methods leads to few false positives or 
false negatives. Comparison of the combination of predic-
tors (Chartis and CT) and CT alone resulted in a small but 
nonsignificant difference in favor of the combined model.
Gompelmann et al40 also retrospectively compared Chartis 
to CT-fissure analysis in 69 patients. A complete fissure was 
defined as .90% of the fissure present. A positive result was 
defined as a TLVR $350 mL. The Chartis method had an 
accuracy of 74% and the HRCT fissure analysis an accuracy 
of 77%, meaning both methods are similar in classifying 
patients to respond or not respond to EBV treatment. Both 
methods were concordant in two-thirds of the patients, similar 
to the study of Schuhmann et al.37
Reymond et al41 compared CT-fissure analysis to the 
Chartis measurement in patients with severe emphysema, 
but not its clinical response. This retrospective study showed 
an agreement of 73% between the two methods, with a high 
sensitivity and few false negatives.
Although these studies were retrospective and origi-
nally not designed to compare these methods, Chartis and 
CT-fissure analysis appear to be equivalent to correctly 
predict a positive or negative response to EBV. New and 
preferably prospective studies are required to confirm this 
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The role of the fissure in emphysema
is superior to a single method to successfully predict the 
response to EBV.
Clinical application
Another question is whether the measurement of CV is 
indeed correlated with the results of BLVR.
The first study to correlate the success of EBV placement 
to CV was the Endobronchial Valve for Emphysema Palliation 
Trial (VENT), performed by Sciurba et al.6 They randomly 
assigned patients to endobronchial therapy, independent of 
CV or fissure completeness. Although there was a significant 
improvement of pulmonary function in the treated patients, in 
a post hoc analysis, they found an enhanced effect of therapy 
in patients with complete fissures (.90% complete) on CT.
A European multicenter study by Herth et al,44 designed as 
a validation study for the Chartis system, compared patients 
with and without CV. There were significantly more respond-
ers in the group without CV (target lung volume reduction of 
350 mL or more). The TLVR was 743 versus 99 mL in favor 
of the group without CV. Furthermore, the FEV
1
 increased 
(mean percentage 16 vs 1). The 6 minutes walking distance 
and St George’s Respiratory Questionnaire were in favor of 
the collateral negative group, but not significant.
An important study is the BeLieVeR-HIFi study by Davey 
et al;39 a double-blind sham controlled trial. Patients were 
selected for bronchoscopic intervention based on the CT-
scan alone. They found an increase of the FEV
1
 of 8.77%. 
However, the CV was also measured to compare these two 
methods. Of the 25 patients with intact fissures and who 
received EBVs, CV was found in four patients. These patients 
had no benefit or less benefit from the treatment.
More recently, Klooster et al3 published the STELVIO-
trial, a randomized controlled trial to compare endobronchial-
valve treatment with standard medical care. Only patients 
with a complete or near complete fissure were included. 
CV was measured using the Chartis measurement system. 
Patients without interlobar CV were randomized to treatment 
with EBVs or as control. The EBV group improved signifi-
cantly in FEV
1
 (+22.7%), FVC (+442 mL), and 6 minutes 
walking distance (+106 m).3
An important question is whether the HRCT and Chartis 
measurement should always be used to determine if a patient 
is a potential responder to EBVs. Schuhmann et al37 reported 
a high response rate of almost 65% if the fissure was .90% 
complete. Nevertheless, this means there is a significant 
proportion of patients without response. This is also shown 
by the studies by Klooster et al3 and Davey et al.39 As shown 
in both studies, an HRCT with complete or near complete 
fissure (.90%) does not predict the presence of CV in all 
patients. Therefore, the Chartis measurement is probably use-
ful in all patients who are eligible for treatment with EBVs 
based on fissure completeness.
However, if the fissure is not (near) complete (,80%–90%), 
the chance of success is very small, and it is probably not 
necessary to perform a Chartis measurement.37 The combina-
tion of a complete fissure on HRCT and no CV with Chartis 
measurement should result in an atelectasis of the target lobe. 
If nevertheless, there is no response, there is most likely a 
problem at the endobronchial level (forgotten subsegment, 
misplaced valve, wrong sizing), and a re-bronchoscopy might 
resolve the problem.6,46
Airway bypass
Although this review mainly focuses on BLVR using EBVs, 
the concept of CV has also been used in the treatment of 
emphysema with so called “airway bypasses”.52 With this 
method, a direct passage between the lung parenchyma and 
large airways or through the thorax is created, allowing air to 
exit the lung, and thus bypassing the expiratory flow limitation. 
CV then should ensure the exit of air and clinical benefit. Two 
approaches using the airway bypass have been investigated. 
The transthoracic airway bypass approach has been described 
by Saad Junior et al53 and Moore et al.54 Saad Junior et al53 
performed this procedure in three patients with emphysema. 
These patients reported improvement of symptoms. However, 
due to the small number treated, no statistical analysis was 
performed.53 Moore et al54 first performed an ex vivo study and 
found an increase in the expiratory flow (169–235 mL; P,0.05) 
after insertion of an extrapulmonary airway bypass in seven 
explanted emphysematous lungs. After that, an in vivo study 
was performed in four patients. There was a reduction of total 
lung capacity in all patients and an increase of the FEV
1
 in three 
patients.54 A larger study (trial ID: ACTRN12610000190000) 
using the transthoracic airway bypass approach was prema-
turely stopped due to lack of funding.55
The bronchoscopic approach to create airway bypasses 
using drug-eluting transbronchial airway stents has been 
extensively studied in severe emphysema patients. In the 
“EASE-trial” by Shah et al,56 a multicentre, randomized, 
full sham bronchoscopy controlled trial, 319 patients were 
randomized and 212 were assigned to airway bypasses. 
Although after 1 day the pulmonary function significantly 
improved, showing a strong signal for proof of concept, there 
was no sustained long-term effect at 6 months or 1 year due 
to closure of the created bypasses.56 There are no other larger 
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is known about the optimal patient selection criteria, number 
of airway bypasses, and optimal target areas.
Conclusion
Endobronchial lung volume reduction is a promising and 
proven effective therapy for selected patients with emphy-
sema. The absence of interlobar CV is the most discrimi-
nating factor for therapeutic success, as this may prevent 
the intended lobar atelectasis after valve placement. CV 
is generated through incomplete lobar fissures. Therefore, 
only patients with complete fissures and no CV can be 
selected for endobronchial therapy. Both CT-fissure analysis 
(indirect) and Chartis measurement (direct) appear to suc-
cessfully predict the presence of CV and thus the success 
rate of endobronchial therapy. Both methods have specific 
pros and cons. However, a combination of the two methods 
most probably provides the highest accuracy and has proven 
to successfully predict a positive or negative treatment 
response. This approach enables personalized medicine and 
provides an excellent treatment strategy in selected patients 
with the right phenotype of emphysema, whilst it avoids the 
possibility of unsuitable patients with the wrong phenotype 
undergoing useless treatment.
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